Strategies to improve adherence to interventions {11c}
post-kidney-transplant
Participant adherence to the trial protocol is expected to be high because the investigational medicinal product is used for routine clinical post-kidney-transplant care, study visits are implemented within routine outpatient care and no additional invasive procedures are necessary. Adherence will be improved by concise study information leaflets and calls to participants every 2 weeks performed by the study team. Medical adherence will be monitored prospectively using a patient diary. Additional electronic drug monitoring using MEMS® Buttons (AARDEX Group, Switzerland) on TAC blisters, the BAASIS© questionnaire (see 